HMGB1 and Cognitive impairment: In this respect, although no discernible disparity in the impact of dexmedetomidine on the HMGB1 levels was observed between the groups, the Mini-Cog© test is significant in that it provided comprehensive information to patients and their caregivers, in addition to the meticulous evaluation of their susceptibility to cognitive impairment during the perioperative period.